PacBio Eyes Clinical Diagnostic Market for Third-Gen Sequencing Platform | GenomeWeb
This article has been updated from a previous version to clarify the timeline for the expected performance of the SMRT technology.
NEW YORK (GenomeWeb News) — A Pacific Biosciences official said today that the firm has identified clinical diagnostics as a key market for the single-molecule real-time sequencing platform that it plans to launch commercially in 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.